Report Summary
Eternity Insights has published a new study on Global China Contrast Agents Market focusing on key segments as by Type (Iodine Preparations, Gadolinium Preparations, Others), by Application (X-CT, MRI, Ultrasonic, Others), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global China Contrast Agents Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
China Contrast Agents Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global China Contrast Agents Market Size, 2018-2028 (USD Million)
To learn more about this report
Global China Contrast Agents Market Segmentation:
China Contrast Agents Market, By Type
- Iodine Preparations
- Gadolinium Preparations
- Others
China Contrast Agents Market, By Application
- X-CT
- MRI
- Ultrasonic
- Others
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global China Contrast Agents market in terms of demand generation. The China Contrast Agents market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for China Contrast Agents market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global China Contrast Agents Market Taxonomy:
To learn more about this report
Global China Contrast Agents Market Competitive Landscape
The global China Contrast Agents market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- Bayer
- GE Healthcare
- Bracco Imaging
- Guerbet Group
- Hengrui Medicine
- YRPG
- Lantheus
- BeiLu Pharma
- Starrypharm
- Ehaini
- Hunan Hansen Pharmaceutical Co.
- Ltd.
- Hovione FarmaCiencia
- Interpharma
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Iodine Preparations, Gadolinium Preparations, Others |
| By Application Outlook |
X-CT, MRI, Ultrasonic, Others |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Bayer, GE Healthcare, Bracco Imaging, Guerbet Group, Hengrui Medicine, YRPG, Lantheus, BeiLu Pharma, Starrypharm, Ehaini, Hunan Hansen Pharmaceutical Co., Ltd., Hovione FarmaCiencia, Interpharma |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Contrast Agents Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Analysis by Types
2.1 Overall Market Performance(Volume)
2.1.1 Iodine Preparations (Volume)
2.1.2 Gadolinium Preparations (Volume)
2.1.3 Others (Volume)
2.2 Overall Market Performance(Value)
2.2.1 Iodine Preparations (Value)
2.2.2 Gadolinium Preparations (Value)
2.2.3 Others (Value)
3 Product Application Market
3.1 Overall Market Performance (Volume)
3.1.1 X-CT (Volume)
3.1.2 MRI (Volume)
3.1.3 Ultrasonic (Volume)
3.1.4 Others (Volume)
4 Manufacturers Profiles/Analysis
4.1 Bayer
4.1.1 Bayer Profiles
4.1.2 Bayer Product Information
4.1.3 Bayer Contrast Agents Business Performance
4.1.4 Bayer Contrast Agents Business Development and Market Status
4.2 GE Healthcare
4.2.1 GE Healthcare Profiles
4.2.2 GE Healthcare Product Information
4.2.3 GE Healthcare Contrast Agents Business Performance
4.2.4 GE Healthcare Contrast Agents Business Development and Market Status
4.3 Bracco Imaging
4.3.1 Bracco Imaging Profiles
4.3.2 Bracco Imaging Product Information
4.3.3 Bracco Imaging Contrast Agents Business Performance
4.3.4 Bracco Imaging Contrast Agents Business Development and Market Status
4.4 Guerbet Group
4.4.1 Guerbet Group Profiles
4.4.2 Guerbet Group Product Information
4.4.3 Guerbet Group Contrast Agents Business Performance
4.4.4 Guerbet Group Contrast Agents Business Development and Market Status
4.5 Hengrui Medicine
4.5.1 Hengrui Medicine Profiles
4.5.2 Hengrui Medicine Product Information
4.5.3 Hengrui Medicine Contrast Agents Business Performance
4.5.4 Hengrui Medicine Contrast Agents Business Development and Market Status
4.6 YRPG
4.6.1 YRPG Profiles
4.6.2 YRPG Product Information
4.6.3 YRPG Contrast Agents Business Performance
4.6.4 YRPG Contrast Agents Business Development and Market Status
4.7 Lantheus
4.7.1 Lantheus Profiles
4.7.2 Lantheus Product Information
4.7.3 Lantheus Contrast Agents Business Performance
4.7.4 Lantheus Contrast Agents Business Development and Market Status
4.8 BeiLu Pharma
4.8.1 BeiLu Pharma Profiles
4.8.2 BeiLu Pharma Product Information
4.8.3 BeiLu Pharma Contrast Agents Business Performance
4.8.4 BeiLu Pharma Contrast Agents Business Development and Market Status
4.9 Starrypharm
4.9.1 Starrypharm Profiles
4.9.2 Starrypharm Product Information
4.9.3 Starrypharm Contrast Agents Business Performance
4.9.4 Starrypharm Contrast Agents Business Development and Market Status
4.10 Ehaini
4.10.1 Ehaini Profiles
4.10.2 Ehaini Product Information
4.10.3 Ehaini Contrast Agents Business Performance
4.10.4 Ehaini Contrast Agents Business Development and Market Status
4.11 Hunan Hansen Pharmaceutical Co., Ltd.
4.12 Hovione FarmaCiencia
4.13 Interpharma
5 Market Performance for Manufacturers
5.1 China Contrast Agents Sales (K Units) and Market Share by Manufacturers 2014-2020
5.2 China Contrast Agents Revenue (M USD) and Market Share by Manufacturers 2014-2020
5.3 China Contrast Agents Price (USD/Unit) of Manufacturers 2014-2020
5.4 China Contrast Agents Gross Margin of Manufacturers 2014-2020
5.5 Market Concentration
6 Regions Market Performance for Manufacturers
6.1 South China Market Performance for Manufacturers
6.1.1 South China Contrast Agents Sales (K Units) and Share of Manufacturers 2014-2020
6.1.2 South China Contrast Agents Revenue (M USD) and Share of Manufacturers 2014-2020
6.1.3 South China Contrast Agents Price (USD/Unit) of Manufacturers 2014-2020
6.1.4 South China Contrast Agents Gross Margin of Manufacturers 2014-2020
6.1.5 Market Concentration
6.2 East China Market Performance for Manufacturers
6.2.1 East China Contrast Agents Sales (K Units) and Share of Manufacturers 2014-2020
6.2.2 East China Contrast Agents Revenue (M USD) and Share of Manufacturers 2014-2020
6.2.3 East China Contrast Agents Price (USD/Unit) of Manufacturers 2014-2020
6.2.4 East China Contrast Agents Gross Margin of Manufacturers 2014-2020
6.2.5 Market Concentration
6.3 Southwest China Market Performance for Manufacturers
6.3.1 Southwest China Contrast Agents Sales (K Units) and Share of Manufacturers 2014-2020
6.3.2 Southwest China Contrast Agents Revenue (M USD) and Share of Manufacturers 2014-2020
6.3.3 Southwest China Contrast Agents Price (USD/Unit) of Manufacturers 2014-2020
6.3.4 Southwest China Contrast Agents Gross Margin of Manufacturers 2014-2020
6.3.5 Market Concentration
6.4 Northeast China Market Performance for Manufacturers
6.4.1 Northeast China Contrast Agents Sales (K Units) and Share of Manufacturers 2014-2020
6.4.2 Northeast China Contrast Agents Revenue (M USD) and Share of Manufacturers 2014-2020
6.4.3 Northeast China Contrast Agents Price (USD/Unit) of Manufacturers 2014-2020
6.4.4 Northeast China Contrast Agents Gross Margin of Manufacturers 2014-2020
6.4.5 Market Concentration
6.5 North China Market Performance for Manufacturers
6.5.1 North China Contrast Agents Sales (K Units) and Share of Manufacturers 2014-2020
6.5.2 North China Contrast Agents Revenue (M USD) and Share of Manufacturers 2014-2020
6.5.3 North China Contrast Agents Price (USD/Unit) of Manufacturers 2014-2020
6.5.4 North China Contrast Agents Gross Margin of Manufacturers 2014-2020
6.5.5 Market Concentration
6.6 Central China Market Performance for Manufacturers
6.6.1 Central China Contrast Agents Sales (K Units) and Share of Manufacturers 2014-2020
6.6.2 Central China Contrast Agents Revenue (M USD) and Share of Manufacturers 2014-2020
6.6.3 Central China Contrast Agents Price (USD/Unit) of Manufacturers 2014-2020
6.6.4 Central China Contrast Agents Gross Margin of Manufacturers 2014-2020
6.6.5 Market Concentration
6.7 Northwest China Market Performance for Manufacturers
6.7.1 Northwest China Contrast Agents Sales (K Units) and Share of Manufacturers 2014-2020
6.7.2 Northwest China Contrast Agents Revenue (M USD) and Share of Manufacturers 2014-2020
6.7.3 Northwest China Contrast Agents Price (USD/Unit) of Manufacturers 2014-2020
6.7.4 Northwest China Contrast Agents Gross Margin of Manufacturers 2014-2020
6.7.5 Market Concentration
7 China Contrast Agents Market Performance (Sales Point)
7.1 China Contrast Agents Sales (K Units) and Market Share by Regions 2014-2020
7.2 China Contrast Agents Revenue (M USD) and Market Share by Regions 2014-2020
7.3 China Contrast Agents Price (USD/Unit) by Regions 2014-2020
7.4 China Contrast Agents Gross Margin by Regions 2014-2020
8 Development Trend for Regions (Sales Point)
8.1 China Contrast Agents Sales and Growth, Sales Value and Growth Rate2014-2020
8.2 South China Contrast Agents Sales and Growth, Sales Value and Growth Rate2014-2020
8.3 East China Contrast Agents Sales and Growth, Sales Value and Growth Rate2014-2020
8.4 Southwest China Contrast Agents Sales and Growth, Sales Value and Growth Rate2014-2020
8.5 Northeast China Contrast Agents Sales and Growth, Sales Value and Growth Rate2014-2020
8.6 North China Contrast Agents Sales and Growth, Sales Value and Growth Rate2014-2020
8.7 Central China Contrast Agents Sales and Growth, Sales Value and Growth Rate2014-2020
8.8 Northwest China Contrast Agents Sales and Growth, Sales Value and Growth Rate2014-2020
9 Upstream Source, Technology and Cost
9.1 Upstream Source
9.2 Technology
9.3 Cost
10 Channel Analysis
10.1 Market Channel
10.2 Distributors
11 Consumer Analysis
11.1 X-CT Industry
11.2 MRI Industry
11.3 Ultrasonic Industry
11.4 Others Industry
12 Market Forecast 2021-2026
12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
12.1.1 China Contrast Agents Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
12.1.2 China Contrast Agents Sales (K Units) and Growth Rate 2021-2026
12.1.3 South China Contrast Agents Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.4 East China Contrast Agents Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.5 Southwest China Contrast Agents Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.6 Northeast China Contrast Agents Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.7 North China Contrast Agents Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.8 Central China Contrast Agents Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.9 Northwest China Contrast Agents Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.2 Sales (K Units) and Revenue (M USD) Forecast by Types 2021-2026
12.2.1 Overall Market Performance
12.2.2 Iodine Preparations
12.2.3 Gadolinium Preparations
12.2.4 Others
12.3 Sales and Growth Rate Forecast by Application 2021-2026
12.3.1 Overall Market Performance
12.3.2 X-CT
12.3.3 MRI
12.3.4 Ultrasonic
12.3.5 Others
12.4 Price (USD/Unit) and Gross Profit Forecast
12.4.1 China Contrast Agents Price (USD/Unit) Trend 2021-2026
12.4.2 China Contrast Agents Gross Profit Trend 2021-2026
13 Conclusion
